Logo image of DRCT

DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DRCT - US25461T1051 - Common Stock

0.0567 USD
-0.01 (-11.96%)
Last: 1/2/2026, 4:34:58 PM
0.0564 USD
0 (-0.53%)
After Hours: 1/2/2026, 4:34:58 PM
Fundamental Rating

1

Taking everything into account, DRCT scores 1 out of 10 in our fundamental rating. DRCT was compared to 95 industry peers in the Media industry. DRCT may be in some trouble as it scores bad on both profitability and health. DRCT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DRCT has reported negative net income.
In the past year DRCT has reported a negative cash flow from operations.
DRCT had negative earnings in 4 of the past 5 years.
In multiple years DRCT reported negative operating cash flow during the last 5 years.
DRCT Yearly Net Income VS EBIT VS OCF VS FCFDRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

The Return On Assets of DRCT (-42.00%) is worse than 78.95% of its industry peers.
Industry RankSector Rank
ROA -42%
ROE N/A
ROIC N/A
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DRCT Yearly ROA, ROE, ROICDRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

With a Gross Margin value of 31.43%, DRCT is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of DRCT has declined.
DRCT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
DRCT Yearly Profit, Operating, Gross MarginsDRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRCT has more shares outstanding than it did 1 year ago.
DRCT has a worse debt/assets ratio than last year.
DRCT Yearly Shares OutstandingDRCT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
DRCT Yearly Total Debt VS Total AssetsDRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -2.16, we must say that DRCT is in the distress zone and has some risk of bankruptcy.
DRCT has a worse Altman-Z score (-2.16) than 76.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.16
ROIC/WACCN/A
WACC10.7%
DRCT Yearly LT Debt VS Equity VS FCFDRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.37 indicates that DRCT may have some problems paying its short term obligations.
DRCT has a Current ratio of 0.37. This is amonst the worse of the industry: DRCT underperforms 86.32% of its industry peers.
A Quick Ratio of 0.37 indicates that DRCT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, DRCT is doing worse than 86.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
DRCT Yearly Current Assets VS Current LiabilitesDRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

DRCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.65%, which is quite impressive.
Looking at the last year, DRCT shows a very negative growth in Revenue. The Revenue has decreased by -62.46% in the last year.
The Revenue has been growing by 17.76% on average over the past years. This is quite good.
EPS 1Y (TTM)49.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.46%
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%

3.2 Future

DRCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.30% yearly.
DRCT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.39% yearly.
EPS Next Y68.01%
EPS Next 2Y41.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-35.97%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRCT Yearly Revenue VS EstimatesDRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
DRCT Yearly EPS VS EstimatesDRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DRCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRCT Price Earnings VS Forward Price EarningsDRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRCT Per share dataDRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as DRCT's earnings are expected to grow with 41.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.3%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DRCT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

DIRECT DIGITAL HOLDINGS IN-A

NASDAQ:DRCT (1/2/2026, 4:34:58 PM)

After market: 0.0564 0 (-0.53%)

0.0567

-0.01 (-11.96%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners1.53%
Inst Owner Change-28.5%
Ins Owners1.48%
Ins Owner Change-7.51%
Market Cap1.71M
Revenue(TTM)35.37M
Net Income(TTM)-9.46M
Analysts80
Price Target2.04 (3497.88%)
Short Float %2.87%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-707.56%
Min EPS beat(2)-1468.63%
Max EPS beat(2)53.51%
EPS beat(4)1
Avg EPS beat(4)-2044.59%
Min EPS beat(4)-6762.75%
Max EPS beat(4)53.51%
EPS beat(8)1
Avg EPS beat(8)-1272.49%
EPS beat(12)2
Avg EPS beat(12)-831.71%
EPS beat(16)5
Avg EPS beat(16)-613.34%
Revenue beat(2)0
Avg Revenue beat(2)-40.4%
Min Revenue beat(2)-64.81%
Max Revenue beat(2)-15.98%
Revenue beat(4)0
Avg Revenue beat(4)-32.8%
Min Revenue beat(4)-64.81%
Max Revenue beat(4)-14.88%
Revenue beat(8)0
Avg Revenue beat(8)-38.81%
Revenue beat(12)4
Avg Revenue beat(12)-16.24%
Revenue beat(16)6
Avg Revenue beat(16)-7.36%
PT rev (1m)0%
PT rev (3m)-66.67%
EPS NQ rev (1m)-633.33%
EPS NQ rev (3m)-633.33%
EPS NY rev (1m)-160.87%
EPS NY rev (3m)-160.87%
Revenue NQ rev (1m)-55.84%
Revenue NQ rev (3m)-55.84%
Revenue NY rev (1m)-39.84%
Revenue NY rev (3m)-39.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.18
BVpS-0.04
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.43%
FCFM N/A
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
F-Score3
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.7%
Cap/Sales 0.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z -2.16
F-Score3
WACC10.7%
ROIC/WACCN/A
Cap/Depr(3y)14.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.46%
EPS Next Y68.01%
EPS Next 2Y41.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%
Revenue Next Year-35.97%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-435.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-352.53%
OCF growth 3YN/A
OCF growth 5YN/A

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

ChartMill assigns a fundamental rating of 1 / 10 to DRCT.


What is the valuation status of DIRECT DIGITAL HOLDINGS IN-A (DRCT) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIRECT DIGITAL HOLDINGS IN-A (DRCT). This can be considered as Overvalued.


What is the profitability of DRCT stock?

DIRECT DIGITAL HOLDINGS IN-A (DRCT) has a profitability rating of 0 / 10.


Can you provide the financial health for DRCT stock?

The financial health rating of DIRECT DIGITAL HOLDINGS IN-A (DRCT) is 0 / 10.